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      publication of this article, the affiliation for
     Michael R. Dueñas incorrectly indicated that
       he is retired. Affiliation 11 has been corrected
           to Alzheimer’s & Dementia) convened an interdisciplinary discussion in 2019 to iden-
            tify a path to expedite the development of retinal biomarkers capable of identifying
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      to read: “Chief Public Health Officer, American
   Optometric Association, Washington, D.C.”            biological changes associated with AD, and for tracking progression of disease sever-
            ity over time. As different retinal imaging modalities provide different types of struc-
          tural and/or functional information, the discussion reflected on these modalities and
          their respective strengths and weaknesses. Discussion further focused on the impor-
              tance of defining the context of use to help guide the development of retinal biomark-
             ers. Moving from research to context of use, and ultimately to clinical evaluation, this
           article outlines ongoing retinal imaging research today in Alzheimer’s and other brain
           diseases, including a d iscussion of future directions for this area of study.
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